Bone Metastasis Market – Bone-Modifying Agents Expanding in...

added blog Health

2026-08-05 11:09:34 -

Bone Metastasis Market – Bone-Modifying Agents Expanding in Prostate Cancer Care

Market Overview The bone metastasis market is accelerating as bone-modifying agents expand their role in prostate cancer care, where skeletal-related events remain a major source of morbidity despite advances in androgen receptor pathway inhibition. Denosumab, zoledronic acid, and radium-223 now form a multimodal backbone for preventing pathologic fractures, spinal cord compression, and the...

0 Comments 0 Shares 308 Views 0 Reviews